Study examines why a pharma brand’s early sales are not a trusted predictor for total lifetime value-it’s about driving waves of growth.
Steve Waddell
Advertisement
Articles by Steve Waddell
Advertisement
Latest Updated Articles
Launch for Long-Term SuccessMay 9th 2017
Advertisement
Advertisement
Trending on PharmExec
1
M&A Roundup: Lisata Therapeutics Acquires Marea Therapeutics, mAbxience Enters Collaboration with Sandoz
2
FDA Approves Fayuvi for Pediatric Patients with Sanfilippo Syndrome Type A
3
Why Executive MFN Deals Aren't Enough: Q&A with Joe Cunningham
4
Pharmaceutical Executive Daily: FDA Approves Fayuvi
5